Belite Bio Chief Scientific Officer Nathan L. Mata Sells 1,000 ADS Shares Under Rule 10b5-1 Plan

Nathan L. Mata, Chief Scientific Officer of Belite Bio, Inc. (BLTE), sold 1,000 American Depositary Shares (ADS) on April 16, 2026, through a pre-arranged Rule 10b5-1 trading plan adopted on December 10, 2025. The sales were executed in seven separate transactions at weighted average prices ranging from $158.28 to $164.12 per share. Following these transactions, Mata's direct holdings decreased from 15,666 ADS to 14,666 ADS. Each ADS represents one ordinary share of the company. The sales were conducted in compliance with SEC regulations governing insider trading, with the transactions executed at varying price points within specified ranges for each batch. This filing represents routine insider trading activity under a pre-established plan rather than discretionary market timing.